SCHEMBL6890119

SCHEMBL6890119

CCCCN(C)C(=O)c1ccccc1N1CCNCC1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.45
GAA P10253 1/20 0.45
HPGD P15428 1/20 0.45
TSHR P16473 1/20 0.45
SIGMAR1 Q99720 2/20 0.43
HSP90AA1 P07900 2/20 0.42
ADRB1 P08588 2/20 0.42
HTR2A P28223 4/20 0.42
HTR2C P28335 4/20 0.42
HTR1A P08908 1/20 0.42
DRD2 P14416 1/20 0.42
DRD4 P21917 1/20 0.42
DRD3 P35462 1/20 0.42
HCRTR1 O43613 2/20 0.42
HCRTR2 O43614 2/20 0.42
SLC6A4 P31645 3/20 0.41
KCNH2 Q12809 1/20 0.41
NAMPT P43490 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3192640 0.92 ADRB1 (0.44) SIGMAR1HSP90AA1ADRB1HTR2AHTR2C
SCHEMBL4507584 0.81 ADRB1 (0.51) CYP1A2HPGDTSHRSIGMAR1ADRB1
SCHEMBL5332592 0.80 HCRTR1 (0.51) ADRB1HTR2AHTR2CHTR1ADRD2
SCHEMBL4062289 0.79 ADRB1 (0.49) CYP1A2HPGDTSHRSIGMAR1ADRB1
SCHEMBL9765989 0.76 ADRB1 (0.49) CYP1A2HPGDTSHRSIGMAR1ADRB1
SCHEMBL27818370 0.76 ADRB1 (0.51) CYP1A2TSHRSIGMAR1ADRB1HTR2A
SCHEMBL21891714 0.75 GAA (0.56) CYP1A2GAAHPGDTSHRHSP90AA1
SCHEMBL6132585 0.75 TSHR (0.56) GAATSHRSIGMAR1ADRB1HTR2A
SCHEMBL14648298 0.74 HCRTR1 (0.53) CYP1A2GAAHTR1AHCRTR1HCRTR2
SCHEMBL4458672 0.73 ADRB1 (0.56) CYP1A2HPGDTSHRSIGMAR1ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6770649-B2 PIPERIZINE COMPOUNDS USEFUL FOR TREATING IRRITABLE BOWEL SYNDROME SOLVAY PHARMACEUTICALS GMBH (DE) 2004-08-03 US disclosed